AxoGen: 4Q Earnings Snapshot

Associated Press
Updated ·1 min read

ALACHUA, Fla. (AP) _ AxoGen Inc. (AXGN) on Monday reported a loss of $7 million in its fourth quarter.

On a per-share basis, the Alachua, Florida-based company said it had a loss of 18 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 10 cents per share.

The regenerative medicine company posted revenue of $28.2 million in the period.

For the year, the company reported that its loss widened to $29.1 million, or 74 cents per share. Revenue was reported as $106.7 million.

AxoGen expects full-year revenue in the range of $124 million to $128 million.

AxoGen shares have dropped 18% since the beginning of the year. In the final minutes of trading on Monday, shares hit $14.60, a decrease of 19% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXGN at https://www.zacks.com/ap/AXGN